Becton, Dickinson and Company
A prospective, non-randomized single arm study using the HemoSphere Alta Advanced Monitoring Platform and associated devices in adult subjects. Data collected from enrolled study subjects will be used for continual device development purposes.
Inclusion Criteria: 1. Signed informed consent 2. Age ≥ 18 years 3. Planned monitoring with a pulmonary artery catheter 4. Patient scheduled to undergo cardiac or liver transplant surgery lasting \> 2 hours 5. Additional criteria for Sub-Cohort A (RVF) 1. Possible Right Ventricular Dysfunction/Failure based on pre-operative assessment of previous Transthoracic Echocardiogram (TTE) 2. Planned Transesophageal Echocardiogram (TEE) assessment during the operative procedure 6. Additional criteria for Sub-Cohort B (CAI) 1. Age ≥ 45 years 2. Planned cardiac surgery with Cardiopulmonary…
Subjects with planned monitoring with a pulmonary artery catheter in the operating room, will be monitored with the above listed devices.
Arctuva estimate
Verify or correct the compensation shown for this listing.